Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott Laboratories fell on its latest earnings report, but I view this as a buying opportunity. Read the latest analysis on ...

McCormick & Company, Incorporated ( MKC) Q4 2025 Earnings Call January 22, 2026 8:00 AM EST ...

Tour statistician Edoardo Molinari breaks down how Griffin went from a solid tour pro to a top player in the world.

McCormick & Company, Incorporated (NYSE:MKC) Q4 2025 Earnings Call Transcript January 22, 2026 McCormick & Company, Incorporated misses on earnings expectations. Reported EPS is $0.86 EPS, ...

Detailed price information for Mccormick & Company (MKC-N) from The Globe and Mail including charting and trades.

For the third quarter, the difference between our GAAP results and adjusted results consists of the following items, ...

Thank you, Allison, and thanks, everyone, for joining the call today. Adjusted EPS was $1.64, driven by an impressive 5.6% core sales growth, primarily reflecting broad-based strength at Aerospace & ...

The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with neuropathic corneal pain, according to a press release from Okyo.

Join Infosecurity Magazine’s industry-leading cybersecurity webinars to enhance your information security strategy, learn about the latest technology developments and hear insights from inspiring ...